Cantor Fitzgerald and Silverstein Properties have topped off Shorehaven, the first phase of South Pier, a $1.8 billion mixed-use development on Tempe Town Lake in Tempe, Ariz. The master-planned ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

Cantor Equity Partners I, a special purpose acquisition company affiliated with Cantor Fitzgerald, filed for a $200 million initial public offering. Howard Lutnick, chairman and chief executive ...

Cantor Fitzgerald came out and argued on Monday morning that short-term market bullishness should hold especially with a stimulus coming from the upcoming U.S. presidential election, but bigger ...

Cantor Fitzgerald raised the firm’s price target on MicroStrategy (MSTR) to $312 from $200 and keeps an Overweight rating on the shares. MicroStrategy, whose core business is being a business ...

Cantor Fitzgerald assumed coverage of Palo Alto Networks (PANW) with an Overweight rating and price target of $415, up from $400. Several online sources reported yesterday that Palo Alto has been ...

Howard Lutnick, the head of investment bank Cantor Fitzgerald and financial-technology company BGC Group BGC, is breaking into the interest-rate futures market by launching a new exchange on ...

Investment firm Cantor Fitzgerald recently penned a research note on the semiconductor space, noting that recent issues from ...

Cantor Fitzgerald recently raised the price target on the stock to $225 from $200 and kept an Overweight rating on the shares into Q3 earnings season. The investment firm sees a tale of two ...

We recently compiled a list of Cantor Fitzgerald's Top Internet Stocks: Best Stocks To Buy According To $13.2 Billion Firm.

https://www.tipranks.com/news/the-fly/monte-rosa-therapeutics-price-target-raised-to-20-from-16-at-piper-sandler Cantor Fitzgerald raised the firm’s price target on ...

Cantor Fitzgerald lowered the firm’s price target on Humana (HUM) to $290 from $395 and keeps a Neutral rating on the shares. Cantor is less confident than sentiment appears that all the risks ...